[go: up one dir, main page]

CH222946A - Process for the preparation of a monoester of the androstene series. - Google Patents

Process for the preparation of a monoester of the androstene series.

Info

Publication number
CH222946A
CH222946A CH222946DA CH222946A CH 222946 A CH222946 A CH 222946A CH 222946D A CH222946D A CH 222946DA CH 222946 A CH222946 A CH 222946A
Authority
CH
Switzerland
Prior art keywords
trans
androstene
reaction
diol
monoester
Prior art date
Application number
Other languages
German (de)
Inventor
Gesellschaft Fuer Chemis Basel
Original Assignee
Chem Ind Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Ind Basel filed Critical Chem Ind Basel
Publication of CH222946A publication Critical patent/CH222946A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Description

  

  Verfahren zur Darstellung eines     Monoesters    der     Androstenreihe.            Es    wurde gefunden,     dass    man zu einem  Monoester der     Androstenreihe    gelangen kann,  wenn man einen     gemischten        Diester    des     45,6-          Androsten-3-trane,17-trans-diols    der allge  meinen     Formel     
EMI0001.0011     
         worin        R,

      den     Propionylrest    und     IR"    den     Rest     eines niedrigeren Homologen der     Propion-          säure        bedeutet,    mit     hydrolysierend    wirken  den     Mitteln    behandelt.    Das so ,gewonnene     45,6-Androsten-3-trans,          17-trans-diol-17-propionat    der Formel  
EMI0001.0024     
    bildet farblose     Kristalle,    die bei<B>153,'</B>  schmelzen. Es ist identisch mit der .gemäss  Patent Nr.     2131.8l        herstellbaren    Verbindung.

      Die als Ausgangsstoffe dienenden ge  mischten     Diester    werden     zweckmässig    nur  mit der zur Abspaltung des     3-;Säurerestes     ausreichenden Menge     des.        hydrolysierend     wirkenden     Mittels    behandelt.

   Die Reaktion  lässt sich zum Beispiel in     Methyl-    oder  Äthylalkohol, aber auch in     höheren    Alko  holen, in     Diogan,    Aceton und     dergl.    durch  führen.     Bei    Verwendung von Alkoholen fin  det meist     eine        Umesterung        statt,    so dass zum  Beispiel beträchtlich weniger als die berech  nete Menge Lauge verbraucht     wird.    Man     ist         somit zum     Beispiel    nicht an die     berechnete     Menge Lauge gebunden, sondern kann auch  weniger verwenden.

       Dadurch    sowie durch die  Konzentration der Lauge und der Tempera  tur lässt sich die     Reaktionszeit    günstig beein  flussen.  



  Die Verbindung soll als Zwischenprodukt  zur Herstellung therapeutisch verwendbarer  Stoffe dienen oder selbst therapeutische Ver  wendung finden.  



  <I>Beispiel:</I>       3,74    g     d5,6-Androst,en-3-trans,17-trans-          diol    - 3 -     formiat    - 17 -     propionat    werden mit  500 cm' Methylalkohol versetzt.     Das    ganze  wird längere Zeit (etwa 50     ,Stunden)    bei       Zimmertemperatur    gerührt und allmählich  eine     methylalkoholische    Lösung von 0,56 g       Kaliumhydrogyd        zutropfen    gelassen.

   Nach  dem Neutralisieren wird im Vakuum stark  eingeengt, das Rohprodukt mit Wasser ge  fällt, in Äther aufgenommen und dann der  Äther     abgedampft.    Den Rückstand kristalli  siert man um     und    erhält so das     45.6-Andro-          sten    - 3     -trans    ,17 -     trans-diol    -17 -     propionat    in  Form     farbloser    Nadeln vom F.     15e3     .



  Process for the preparation of a monoester of the androstene series. It has been found that a monoester of the androstene series can be obtained if a mixed diester of the 45,6-androstene-3-trane, 17-trans-diol of the general formula is used
EMI0001.0011
         where R,

      the propionyl radical and IR "denotes the radical of a lower homologue of propionic acid treated with the agents having a hydrolyzing effect. The 45,6-androstene-3-trans, 17-trans-diol-17-propionate of the formula obtained in this way
EMI0001.0024
    forms colorless crystals that melt at <B> 153, '</B>. It is identical to the connection that can be made in accordance with Patent No. 2131.8l.

      The mixed diesters used as starting materials are expediently treated only with the amount of the hydrolyzing agent which is sufficient to split off the 3-acid radical.

   The reaction can be fetched, for example, in methyl or ethyl alcohol, but also in higher alcohols, in diogan, acetone and the like. When alcohols are used, transesterification usually takes place, so that, for example, considerably less than the calculated amount of lye is used. For example, you are not bound to the calculated amount of lye, but can use less.

       This, as well as the concentration of the lye and the temperature, can favorably influence the reaction time.



  The compound is intended to serve as an intermediate for the production of therapeutically useful substances or to find therapeutic use itself.



  <I> Example: </I> 3.74 g of d5,6-androst, en-3-trans, 17-trans-diol - 3 - formate - 17 - propionate are mixed with 500 cm 'of methyl alcohol. The whole is stirred for a long time (about 50 hours) at room temperature and gradually a methyl alcoholic solution of 0.56 g of potassium hydrogen is added dropwise.

   After neutralization, it is strongly concentrated in vacuo, the crude product is precipitated with water, taken up in ether and then the ether is evaporated. The residue is recrystallized and 45.6-androstene-3-trans, 17-trans-diol -17-propionate is obtained in the form of colorless needles of F. 15e3.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Darstellung von. 45,6-An- drosten-3-trans,17-trans-diol-17-propionat, da durch gekennzeichnet, dass man einen ge mischten Diester des 45,6-Androsten-3-trans, 17-trans-diols der allgemeinen Formel EMI0002.0032 worin R1 den Propionylrest und R2 den Rest eines niedrigeren Homologen der Propion- säure bedeutet, PATENT CLAIM: Method for the representation of. 45,6-androstene-3-trans, 17-trans-diol-17-propionate, as characterized in that one mixed diester of 45,6-androstene-3-trans, 17-trans-diol of the general formula EMI0002.0032 where R1 is the propionyl radical and R2 is the radical of a lower homologue of propionic acid, mit hydrolysierend wirken den Mitteln behandelt. Das Verfahrensprodukt ist identisch mit der gemäss Patent Nr. 213181 herstellbaxen Verbindung. <B>UNTERANSPRÜCHE:</B> 1. Verfahren nach Patentanspruch, da durch gekennzeichnet, dass man die Reaktion in indifferenten Lösungsmitteln vornimmt. 2. Verfahren nach Patentanspruch, da durch gekennzeichnet, dass man die Reaktion in Alkoholen vornimmt. 3. Treated with hydrolyzing agents. The product of the process is identical to the compound that can be produced in accordance with Patent No. 213181. <B> SUBClaims: </B> 1. Method according to patent claim, characterized in that the reaction is carried out in inert solvents. 2. The method according to claim, characterized in that the reaction is carried out in alcohols. 3. Verfahren nach Patentanspruch und Unteranspruch 2, dadurch gekennzeichnet, dass man die Reaktion in Methylalkohol vor nimmt. 4. Verfahren nach Patentanspruch, da durch gekennzeichnet, dass nur die zur Ab spaltung eines Säurerestes ausreichende Menge des hydrolysierend wirkenden Mittels verwendet wird. Process according to claim and dependent claim 2, characterized in that the reaction is carried out in methyl alcohol. 4. The method according to claim, characterized in that only the sufficient amount of the hydrolyzing agent to cleave an acid residue is used.
CH222946D 1935-06-18 1935-06-18 Process for the preparation of a monoester of the androstene series. CH222946A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH222946T 1935-06-18
CH207719T 1935-06-18

Publications (1)

Publication Number Publication Date
CH222946A true CH222946A (en) 1942-08-15

Family

ID=25724443

Family Applications (1)

Application Number Title Priority Date Filing Date
CH222946D CH222946A (en) 1935-06-18 1935-06-18 Process for the preparation of a monoester of the androstene series.

Country Status (1)

Country Link
CH (1) CH222946A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3087939A (en) * 1954-08-13 1963-04-30 Syntex Corp Method for the production of 3-keto steroids from the corresponding 3-formates

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3087939A (en) * 1954-08-13 1963-04-30 Syntex Corp Method for the production of 3-keto steroids from the corresponding 3-formates

Similar Documents

Publication Publication Date Title
CH222946A (en) Process for the preparation of a monoester of the androstene series.
CH222950A (en) Process for the preparation of a monoester of the androstene series.
CH222947A (en) Process for the preparation of a monoester of the androstene series.
CH222949A (en) Process for the preparation of a monoester of the androstene series.
CH222951A (en) Process for the preparation of a monoester of the androstane series.
CH222952A (en) Process for the preparation of a monoester of the androstane series.
CH222955A (en) Process for the preparation of a monoester of the androstane series.
CH222948A (en) Process for the preparation of a monoester of the androstene series.
CH222956A (en) Process for the preparation of a monoester of the androstane series.
CH222953A (en) Process for the preparation of a monoester of the androstane series.
CH210723A (en) Process for the preparation of a monoester of the androstene series.
CH222954A (en) Process for the preparation of a monoester of the androstane series.
CH210729A (en) Process for the preparation of a monoester of the androstane series.
CH210725A (en) Process for the preparation of a monoester of the androstene series.
CH210728A (en) Process for the preparation of a monoester of the androstene series.
CH222957A (en) Process for the preparation of a monoester of the androstane series.
CH207719A (en) Process for the preparation of a monoester of the androstane series.
CH210726A (en) Process for the preparation of a monoester of the androstene series.
DE973365C (en) Process for the production of cortisone and hydrocortisone
CH210727A (en) Process for the preparation of a monoester of the androstene series.
DE864254C (en) Process for the production of reductic acid
CH210724A (en) Process for the preparation of a monoester of the androstene series.
AT158408B (en) Process for the preparation of 3-keto acid lactones of the sugar series or their endiols.
DE565157C (en) Process for the production of saturated halogenated alcohols
DE1041944B (en) Process for the preparation of acylated citric acid esters